PSMA-Targeted Liposomes for Therapeutic Delivery into a Prostate Cancer Cell Model. (PubMed, Pharmaceutics) - Sep 27, 2026 - " These findings provide proof-of-concept evidence that PSMA-targeted DUPA-PEG LIPOs can facilitate Talazoparib delivery and, particularly in combination with BI 2536, may enhance antitumor activity in PCa models. Further studies with expanded control groups and larger cohorts are warranted to validate the therapeutic efficacy of this combination strategy and support its further development for PCa treatment."
Journal • Genito-urinary Cancer • Oncology • Prostate Cancer • Solid Tumor
|
|
Bahar Ataeinia; Lital Ben Naim; Miguel Ferreira; Neelum Aziz Yousafzai; Pedram Heidari; Umar Mahmood
|